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Abstract
Insular gliomas most commonly present with drug-
resistant seizures, irrespective of the tumour grade. Even
though surgery is the mainstay of treatment, complex
anatomical location and close proximity to eloquent cortex
makes surgical resection difficult. Herein the authors have
reviewed the literature with regards to seizure control after
surgical management of these tumours. The review does
not address quality of life, or survival benefits of surgery. In
summary, excision of these gliomas significantly improves
seizure control, and extent of resection along-with trans-
cortical approach are important predictors of seizure
outcome.
Keywords: seizure control, insular glioma, surgical
resection.
Introduction
Insula, often referred to as the fifth lobe of the brain, is a
common site for gliomas; 25% of intracranial low-grade
(WHO Grade I and II) and 10% high-grade gliomas (WHO
Grade III and IV) are present in the insular region.1 Due to
its challenging anatomy, being covered by the three
opercula; frontal, temporal and parietal, and its close
vicinity to eloquent areas and important vasculature
(middle cerebral artery and its branches including the
lenticulostriate arteries), surgical management of insular
gliomas is challenging (Figure 1,2).2,3 Apart from a variety
of presenting symptoms, insular gliomas often tend to be
epileptogenic due to the complex neural connections
present there, resulting in worsening quality of life and
cognitive impairment.1,4 Low grade insular gliomas have a
higher likelihood of causing epileptic seizures (more than
80%) than high-grade insular gliomas. Incidence of these
seizures can be dependent upon tumour grade, type and
location, with low grade gliomas having a higher likelihood
of seizures (more than 80%) than high grade gliomas.5
Few studies have reported outcomes with regards to
seizure control after glioma resection, and different factors
have been attributed to affect seizure control without
consensus. We have reviewed the literature to evaluate and
summarize the current evidence on seizure freedom after
surgical resection of insular gliomas.
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Figure-1: Axial section of MRI brain T2 weighted image, showing hyperintense
lesion in the left insular region extending into the temporal lobe, and
causing mild mass effect. This patient had history of seizures for 1 year,
and underwent maximum safe resection of the lesion. Histopathology
was reported as Oligodendroglioma grade II.
Figure-2: Axial section of MRI brain T1 post-contrast image of the same patient,
showing hypo-intense signal changes in the left insular region and
temporal lobe, with no contrast enhancement.
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Review of Evidence
In one of the earliest studies, Von Lehe et al., retrospectively
reviewed 24 patients who had undergone surgical
resection of insular lesions for epilepsy.6 Eleven (45.8%)
patients in their series had non-neoplastic lesions, whereas
13 (54.2%) patients had glial/glioneural tumours.6 The
mean follow-up time in their study was 37.5 months.6
Seven (29.1%) patients had sub-total resection of the
tumour due to eloquent area involvement, while rest had
gross total resection.6 They used the International League
against Epilepsy (ILAE) classification to assess seizure
outcome, and reported that 15 patients were totally seizure
free (62.5%, ILAE 1) and 4 more patients had a significant
seizure control (ILAE 2 & 3) at follow-up.6,7 Tamara et., al
studied predictors of 12-month post-operative seizure
control in 52 patients with low grade insular glioma
presenting with drug-resistant epilepsy (failure of seizure
control with 2-3 anti-epileptic drugs or AED therapy, as per
the ILAE definition). Thirty-five (67.31%) patients had
attained complete freedom from seizures, 4 (7.69%) had
rare seizures, 8 (15.38%) had meaningful improvement and
5 (9.62%) had no improvement. They concluded that
infiltrative low-grade gliomas had worse seizure control,
and more than 90% extent of resection was a predictor of
good seizure outcome.8
In a retrospective case series, Baran et al., studied trans-
opercular approach for resection of insular gliomas and
long-term seizure control.9 Among the 22 patients in their
study, 15 (68.1%) had presented with seizures, and 18
(81.8%) had low grade gliomas.9 Awake craniotomy was
performed in 11 (50%) patents, and gross total resection
was achieved in 6 (27.3%) patients.9 The average follow-up
time was 33 months. They reported that 20 (90.9%) patients
were seizure free, with 19 patients on one AED and one off
AED, at last follow-up.9 They also found that that the use of
ultrasonic aspirator and neuro-navigation during surgery
improved safety.9 Khatri et al., performed a retrospective
analysis of 41 patients operated for high grade insular
gliomas at their center.10 Thirty-three (80.5%) patients had
excellent seizure control (ILAE 1A) at a mean follow-up of
18.4 months, with more than half of them, 24 (58.5%), on a
single AED.10 They concluded that trans-cortical approach
had better seizure outcomes than trans-sylvian approach.10
Wang et al. published the largest retrospective case series
comprising of 109 patients who had presented with
seizures, and were operated for insular gliomas.3 Pre-
operative seizure duration was 6 months (median), and
majority (77%) had frequent seizures. Refractory seizures
were present in 84 (77%) patients.3 Almost half (52, 48%)
patients had more than 70% extent of tumour resection,
and 48 (44%) patients underwent a second surgery after
tumour progression. The median follow-up in their series
was 48 months. They reported freedom from seizures in 74
(68%) patients, at 1 year from surgery.3 Extent of tumour
resection was found to be a predictor of seizure control,
and seizure recurrence was associated with disease
progression.3 In another similar, recent retrospective
analysis of giant insular gliomas, Rossi et al., studied 95
patients, of which 70 (73.7%) had undergone gross total
resection.11 They concluded that suboptimal tumour
resection was associated with inadequate seizure control
after surgery.11
Conclusion
Surgical excision of insular glioma leads to effective seizure
control in majority patients. Extent of resection is the single
most important predictor of favourable seizure outcome,
and recurrence of seizures is often associated with
recurrence or progression of disease.
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